Zbiotics has filed a notice of an exempt offering of securities to raise $22,423,339.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Zbiotics is raising up to $22,423,339.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Zachary Abbott played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Zbiotics
Zack Abbott, PhD microbiologist, founded ZBiotics because of the potential genetically engineered probiotics have to improve daily living. Our first product is a probiotic that helps you feel better the day after drinking alcohol. ZBiotics is leveraging its patented technology to create a whole new category of products that help our bodies deal with whatever modern life throws our way. Its genetic engineering as it should be: transparent, responsible, and people first.
To learn more about Zbiotics, visit http://zbiotics.com/
Contact:
Zachary Abbott, Chief Executive Officer
415-723-5294
https://www.linkedin.com/in/zaabbott/
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.